Clinical Trials · NCT06219330
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Fayoum University
- Enrollment
- 45
- Start date
- Jul 2023
- Locations
- 1 site, Egypt
- Primary endpoint
- Cathelicidin LL-37 level in salivary samples from all participants mesured using ELISA